CAS NO: | 892711-75-0 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 |
CDN1163 is an allostericsarco/endoplasmic reticulum Ca2+-ATPase (SERCA)activator that improves Ca2+homeostasis. CDN1163 attenuates diabetes and metabolic disorders[1]. |
||||||||||||||||
IC50& Target |
SERCA[1] |
||||||||||||||||
体外研究 (In Vitro) |
CDN1163 (10 μM; 24 hours; rat cardiac myocyte cells) treatment reduces high glucose-induced resistin and nuclear NFATc expression and increases the phosphorylation of AMPKα in a time-dependent manner[2].
Western Blot Analysis[2]
|
||||||||||||||||
体内研究 (In Vivo) |
CDN1163 (50 mg/kg; intraperitoneal injection; for 5 days; maleob/obmice and leanob/+mice) increases SERCA2 Ca2+-ATPase activity, decreases endoplasmic reticulum (ER) stress-induced cell death in vitro and improves liver Ca2+transport activity. CDN1163 reduces blood glucose levels and improves metabolic parameters and gluconeogenic gene expression, reverses hepatic steatosis, inhibits ER stress and ER stress-induced apoptosis, and improves mitochondrial efficiency inob/obmice in vivo[1].
|
||||||||||||||||
分子量 |
320.39 |
||||||||||||||||
性状 |
Solid |
||||||||||||||||
Formula |
C20H20N2O2 |
||||||||||||||||
CAS 号 |
892711-75-0 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
|
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 100 mg/mL(312.12 mM;Need ultrasonic)
配制储备液
*
请根据半岛bd体育手机客户端 在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的半岛bd体育手机客户端 失效。
In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
*
以上所有助溶剂都可在本网站选购。
|